Catalyst Wire Dossier Catalyst Wire Dossier

Zoledronic acid (Zometa)

zoledronic acid · Novartis
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Zoledronic acid (Zometa), covering 2010-04-26 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL) [Phase 4]

See pricing